Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/7/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Stephen J. Chanock

Wrong Dr. Stephen J. Chanock?

Board Member

National Institutes of Health
31 Center Dr. MSC 2062 Building 31, Room B1-W30
Bethesda, Maryland 20892
United States

Company Description: The National Institutes of Health (NIH) - The Nation's Medical Research Agency - is comprised of 27 Institutes and Centers and is a component of the U. S....   more

Employment History

  • Division of Cancer Epidemiology and Genetics
    National Institutes of Health
  • Chief of Laboratory
    NCI Core Genotyping Facility
  • Director In the Advanced Technology Center
    NCI Core Genotyping Facility
  • Senior Investigator
    NCI Core Genotyping Facility
  • Chief of Translational Genomics
    National Cancer Institute
  • Senior Principal Investigator
    National Cancer Institute
  • Section Head , Section On Genomic Variation
    National Cancer Institute
  • Chief of the Laboratory of Translational Genomics
    U.S. National Cancer Institute
  • Head of the Genomic Variation Section
    U.S. National Cancer Institute
  • Senior Investigator
    U.S. National Cancer Institute
  • Director of the NCI Core Genetics Facility and Co-Director
  • Head of the Variation Section
    Genomics One Corporation
  • Chief, Laboratory
    Translational Genomics
  • Member, Division
    Translational Genomics
  • Member, Division of Cancer Epidemiology and Genetics
    Translational Genomics
  • Chief of the Laboratory
    Translational Genomics of National Cancer Institute

Board Memberships and Affiliations


  • MD
  • M.D.
123 Total References
Web References
Board of Directors | Special Love, 29 May 2014 [cached]
Dr. Stephen Chanock Director, Division of Cancer Epidemiology and Genetics
TIGER 21 - Presenter Bio, 10 Mar 2014 [cached]
Stephen Chanock TIGER 21 - Presenter Bio MEMBER LOGIN
Stephen Chanock
Chief, Laboratory of Translational Genomics of National Cancer Institute
Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children's Hospital and the Dana-Farber Cancer Institute, Boston. Afterwards, he joined the National Cancer Institute, initially in the Pediatric Oncology Branch where he became a Senior Investigator. Several years ago he transitioned to the Division of Cancer Epidemiology and Genetics, where he has lead a highly productive program mapping cancer susceptibility genes. In 2001, he became director of the NCI Core Genotyping Facility and in 2005 he became co-leader of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In 2007, he became the Chief of the newly formed Laboratory of Translational Genomics. Dr. Chanock has published nearly 600 peer review papers and recently received the prestigious Moyent and Rothschild Sabbatical Award at the Institute Curie in Paris, France.
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type - Pancreatic Cancer, 17 Feb 2011 [cached]
"Pancreatic cancer is the newest beneficiary of so-called high-throughput genotyping that, over the past two years, has yielded scores of genetic hot-spots linked to risk for cancer and other diseases," said co-author Stephen J. Chanock, M.D., chief of NCI's Laboratory of Translational Genomics in DCEG.
For more information on Dr. Chanock's research, please go to
"CGEMS allows us to look ..., 30 June 2007 [cached]
"CGEMS allows us to look systematically across the entire human genome and search for common genetic variations that confer risk for prostate cancer, a very common and very complex disease," says Stephen Chanock, MD, director of the NCI Core Genotyping Facility in the Advanced Technology Center.
"This is a very exciting and ..., 2 Aug 2012 [cached]
"This is a very exciting and interesting and, to be honest, important observation in the world of cancer susceptibility," says Stephen Chanock, the chief of translational genomics at the National Cancer Institute in Bethesda, Maryland, who was not involved in the study.
It's still unclear whether testicular cancer is more often caused by de novo mutations instead of inherited ones when compared with other cancer types, says Chanock. But the study provides vital clues about the risk factors for some cancers. "I suspect as we dig deeper into sequencing and family studies, we'll see more and more CNVs representing a portion of the genetic architecture that explains diseases," he says.
Other People with the name "Chanock":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.